Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Bliss Gvs Pharma Limited, is a listed public company incorporated on 11 December, 1984. It is classified as a public limited company and is located in Mumbai, Maharashtra. It's authorized share capital is INR 15.00 cr and the total paid-up capital is INR 10.51 cr.
Bliss Gvs Pharma Limited's operating revenue range is Over INR 500 cr for the financial year ending on 31 March, 2023. It's EBITDA has decreased by 17.44% over the previous year. At the same time, it's book networth has increased by 10.05%.
Read more
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Whole-time Director | Shruti Vishal Rao
Shareholder
|
00731501 | 19 years |
Director | Santosh Laxman Parab
Shareholder
|
01622988 | 9 years |
Whole-time Director | Vibha Gagan Sharma
Shareholder
|
02307289 | 17 years |
Director | Nandkumar Kashinath Chodankar | 02736718 | 1 years |
CFO | Deepak Bhalchandra Sawant
Shareholder
|
<HIDDEN> | 2 years |
CS | Aditi Himanshu Bhatt
Shareholder
|
<HIDDEN> | 7 years |
Managing Director | Gagan Harsh Sharma | 07939421 | 4 years |
Director | Shilpa Bhatia | 08695595 | 5 years |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
The Federal Bank Limited
No. of Loans: 4
Total Amount : 238.0 cr
HDFC Bank Limited
No. of Loans: 1
Total Amount : 1.0 cr
Name | Status | Paid up Capital | Common Directors | Address |
---|---|---|---|---|
PLASTIC INGENUITIES (I) PRIVATE LIMITED |
Active
|
10.0 L | 2 | Maharashtra |
GVSK LLP |
Inactive for e-filing
|
1.0 L | 2 | sh |
KREMOINT PHARMA PRIVATE LIMITED |
Active
|
6.0 L | 3 | Maharashtra |
MAHA ARC LIMITED |
Active
|
300.0 Cr | 1 | Maharashtra |
LAXMITA HEALTHCARE PRIVATE LIMITED |
Strike Off
|
13.0 L | 1 | Goa |
ASOLUTION PHARMACEUTICALS PRIVATE LIMITED |
Active
|
4.9 Cr | 1 | Maharashtra |
EIPII EXPORTS PRIVATE LIMITED |
Active
|
25.0 L | 1 | Maharashtra |
AEROFLEX INDUSTRIES LIMITED |
Active
|
25.9 Cr | 1 | Maharashtra |
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
Bliss GVS International Pte. Limited | Singapore | - | - |
ASTERISK LIFESCIENCES LTD | United Kingdom | - | - |
KREMOINT PHARMA PRIVATE LIMITED | Maharashtra | 1992 | ₹ 6.0 L |
Bliss GVS International Pte. Ltd | Singapore | - | - |
Read more
The incorporation date of BLISS GVS PHARMA LIMITED is 11 December, 1984
The authorized share capital of BLISS GVS PHARMA LIMITED is INR ₹ 15.0 Cr.
The paid-up capital of BLISS GVS PHARMA LIMITED is INR ₹ 10.5 Cr.
The registered address of BLISS GVS PHARMA LIMITED is 102, Hyde Park, Sakivihar Road, Andheri (East). NA MUMBAI Maharashtra - 400072
The CIN number of BLISS GVS PHARMA LIMITED is L24230MH1984PLC034771.